The rising integration of companion diagnostics is transforming the Anti Inflammatory Peptide Market into a centerpiece of personalized healthcare. Chronic inflammatory conditions vary greatly between individual patients, meaning a single standardized drug rarely produces uniform results. By using genetic profiling and biomolecular screening, doctors can map a patient's specific inflammatory...